Treatment for voiding dysfunction caused by substance abuse
Prospective Longitudinal Study on the Treatment Outcomes of Various Treatment Modalities Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction
This study is trying to find the best way to help people with bladder problems caused by drug use, especially in Hong Kong, by testing different treatments and support options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Trial ID | NCT03913819 on ClinicalTrials.gov |
What this trial studies
This observational study aims to address the growing issue of voiding dysfunction related to substance abuse, particularly from drugs like ketamine and methamphetamine. It seeks to establish a standardized treatment protocol based on existing literature and clinical experiences, which includes education, psychosocial support, and a tiered treatment approach involving medications and potential surgical interventions. The study will gather data on treatment outcomes to improve management strategies for affected patients and provide evidence-based recommendations. The research is particularly focused on the challenges faced in Hong Kong's healthcare system regarding access to optimal treatment options.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have experienced voiding dysfunction as a result of substance abuse.
Not a fit: Patients who do not consent to participate or are unable to comply with the treatment protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for patients suffering from voiding dysfunction due to substance abuse.
How similar studies have performed: While there is limited data on similar studies, the approach of standardizing treatment protocols for voiding dysfunction is relatively novel and untested in this specific context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients suffered substance abuse induced voiding dysfunction Exclusion Criteria: * Patient not agreed for consent * Patient that will not comply to our treatment protocol
Where this trial is running
Shatin
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Chi Fai Ng, MD
- Email: ngcf@surgery.cuhk.edu.hk
- Phone: 852-3505-2625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.